[{"address1": "82 Richmond Street East", "city": "Toronto", "state": "ON", "zip": "M5C 1P1", "country": "Canada", "phone": "888-846-3171", "website": "https://www.pharmather.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Fabio  Chianelli", "age": 46, "title": "Founder, Chairman & CEO", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 259960, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Carmelo  Marrelli ACIS, B.Comm., C.A., C.P.A., CGA, CPA", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 57892, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Todd", "age": 66, "title": "Corporate Secretary", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.1583, "open": 0.14, "dayLow": 0.14, "dayHigh": 0.1583, "regularMarketPreviousClose": 0.1583, "regularMarketOpen": 0.14, "regularMarketDayLow": 0.14, "regularMarketDayHigh": 0.1583, "payoutRatio": 0.0, "beta": 3.349, "volume": 15990, "regularMarketVolume": 15990, "averageVolume": 183706, "averageVolume10days": 166330, "averageDailyVolume10Day": 166330, "bid": 0.1453, "ask": 0.1583, "bidSize": 17340, "askSize": 78700, "marketCap": 13986019, "fiftyTwoWeekLow": 0.115, "fiftyTwoWeekHigh": 0.241, "fiftyDayAverage": 0.1442, "twoHundredDayAverage": 0.1612, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 12459355, "profitMargins": 0.0, "floatShares": 71929707, "sharesOutstanding": 88519104, "heldPercentInsiders": 0.18679, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 89012800, "bookValue": 0.018, "priceToBook": 8.777779, "lastFiscalYearEnd": 1717113600, "nextFiscalYearEnd": 1748649600, "mostRecentQuarter": 1732924800, "netIncomeToCommon": -1471197, "trailingEps": -0.04, "enterpriseToEbitda": -8.612, "52WeekChange": -0.20999998, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 0.158, "recommendationKey": "none", "totalCash": 1553213, "totalCashPerShare": 0.018, "ebitda": -1446696, "totalDebt": 0, "quickRatio": 7.074, "currentRatio": 7.074, "returnOnAssets": -0.33602002, "returnOnEquity": -0.63767, "freeCashflow": -1223539, "operatingCashflow": -1700472, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "PHRRF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "marketState": "CLOSED", "shortName": "PharmaTher Holdings Ltd.", "longName": "PharmaTher Holdings Ltd.", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1610116200000, "corporateActions": [], "regularMarketTime": 1746216000, "exchange": "OQB", "messageBoardId": "finmb_671235862", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChange": -0.00029999018, "regularMarketDayRange": "0.14 - 0.1583", "fullExchangeName": "OTC Markets OTCQB", "averageDailyVolume3Month": 183706, "fiftyTwoWeekLowChange": 0.043000005, "fiftyTwoWeekLowChangePercent": 0.37391308, "fiftyTwoWeekRange": "0.115 - 0.241", "fiftyTwoWeekHighChange": -0.08299999, "fiftyTwoWeekHighChangePercent": -0.3443983, "fiftyTwoWeekChangePercent": -20.999998, "earningsTimestamp": 1745524800, "earningsTimestampStart": 1745524800, "earningsTimestampEnd": 1745524800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.04, "fiftyDayAverageChange": 0.01380001, "fiftyDayAverageChangePercent": 0.09570049, "twoHundredDayAverageChange": -0.0031999946, "twoHundredDayAverageChangePercent": -0.019851083, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Newscope Capital Corporation", "nameChangeDate": "2025-05-02", "cryptoTradeable": false, "regularMarketChangePercent": -0.18950738, "regularMarketPrice": 0.158, "displayName": "PharmaTher", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]